INTRODUCTION
(R)-Goniothalamin (1) is a natural product isolated from plants of the Goniothalamus gender. The natural enantiomer presents antiproliferative activity against the following tumor cell lines: cervical (HeLa), kidney (786-0) and adriamycin resistant ovary (NCI-ADR/RES). 1 Posterior reports indicate that goniothalamin may act in the apoptotic process in cancer cells via different mechanisms.
2
Based on the presence of lactam moieties in several biologically active natural product, we decide to search for compounds displaying enhanced cytotoxicity and selectivity. Therefore, we propose the synthesis of lactam derivatives (2a-f) based on the goniothalamin structure. 
RESULTS AND DISCUSSION
The general synthetic route to achieve the derivatives 2a-f stated with aldehydes 3a-f (Scheme 1). To prepare the non-commercial aldehydes 3c and 3d, we used the methodology described in Scheme 2. Reagent 6 was used to homologate the commercial aldehydes 7 and 3f, following deprotection of the acetal to deliver the desired aldehydes.
Aldehyde 3c was obtained in 64% yield with a diastereoisomeric ratio of >99:1, and 3d was obtained in 59% yield with a diastereoisomeric ratio of 16:1. The synthesis of lactams 2a-f began with the formation of imine from aldehyde (3) and LHMDS, followed by the addition of allyl Grignard to generate the primary amine 4. The next step involved the reaction of the amine with acryloyl or crotonoyl chloride leading to the corresponding amide (5). Finally, the lactam derivatives 2 were achieved by treating the corresponding amide with Grubbs' catalyst.
All conditions used and the overall yields are summarized in Table 1 . 
CONCLUSION
To sum up, it was possible to synthesize lactam derivatives of goniothalamin in good overall yields over 3 steps (18-45%). These derivatives are under in vitro evaluation against human tumor cell lines in an antiproliferative assay.
